Background/objective Salivary Mucoepidermoid Carcinoma (MEC) is a heterogeneous malignancy, whose molecular characteristics extend beyond CRTC1/3:MAML2 fusion. This study describes the immunohistochemical expression of CD133, CD44, OCT4, and Mammalian ENA (MENA) in Salivary MEC and their potential relevance to molecular profiling.
No takes yet. Share an insight, caveat, or question.
Alerraqi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: